Indo US Bio-Tech Ltd Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Cr

Standalone Quarterly Results

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Jun'24

Mar'24

Quarterly Analysis Highlights - QoQ

Net Sales

QoQ Growth in quarter ended Sep 2025 is 0.26% vs -7.82% in Jun 2025

Standalone Net Profit

QoQ Growth in quarter ended Sep 2025 is -26.60% vs 27.72% in Jun 2025

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Sep 2025 is -23.77% vs 19.69% in Jun 2025

Interest

QoQ Growth in quarter ended Sep 2025 is -6.67% vs 73.08% in Jun 2025

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025

Compare Quarterly Results Of Indo US Bio-Tech With

Select Peers

Figures in Cr

Standalone Quarterly Results

Change(INR)

Change(%)

Net Sales

30.85

39.77

-8.92

-22.43%

Other Operating Income

0.00

Total Operating income

30.85

39.77

-8.92

-22.43%

Raw Material Cost

0.00

Purchase of Finished goods

0.60

0.28

0.32

114.29%

(Increase) / Decrease In Stocks

3.66

-7.95

11.61

146.04%

Employee Cost

0.34

9.66

-9.32

-96.48%

Power Cost

0.00

Manufacturing Expenses

19.49

20.54

-1.05

-5.11%

Selling and Distribution Expenses

0.00

4.93

-4.93

-100.00%

Other Expenses

2.59

5.12

-2.53

-49.41%

Total Expenditure (Excl Depreciation)

26.68

32.58

-5.90

-18.11%

Operating Profit (PBDIT) excl Other Income

4.17

7.19

-3.02

-42.00%

Other Income

0.03

1.93

-1.90

-98.45%

Operating Profit (PBDIT)

4.20

9.12

-4.92

-53.95%

Interest

0.42

3.30

-2.88

-87.27%

Exceptional Items

0.00

Gross Profit (PBDT)

3.78

5.82

-2.04

-35.05%

Depreciation

0.21

0.98

-0.77

-78.57%

Profit Before Tax

3.56

4.84

-1.28

-26.45%

Tax

0.11

0.64

-0.53

-82.81%

Provisions and contingencies

0.00

Profit After Tax

3.45

4.20

-0.75

-17.86%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

3.45

4.20

-0.75

-17.86%

Equity Capital

20.05

19.00

1.05

5.53%

Face Value

10.00

0.00

Reserves

0.00

Earnings per share (EPS)

1.72

2.21

-0.49

-22.17%

Diluted Earnings per share

1.72

2.16

-0.44

-20.37%

Operating Profit Margin (Excl OI)

13.52%

18.08%

0.00

-4.56%

Gross Profit Margin

12.25%

14.63%

0.00

-2.38%

PAT Margin

11.18%

10.56%

0.00

0.62%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 30.85 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is 0.26% vs -7.82% in Jun 2025

YoY Growth in quarter ended Sep 2025 is 39.15% vs 40.23% in Sep 2024

Quarterly - Standalone Net Profit

Standalone Net Profit 3.45 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is -26.60% vs 27.72% in Jun 2025

YoY Growth in quarter ended Sep 2025 is -20.87% vs 161.08% in Sep 2024

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 4.17 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is -23.77% vs 19.69% in Jun 2025

YoY Growth in quarter ended Sep 2025 is -18.55% vs 97.68% in Sep 2024

Quarterly - Interest

Interest 0.42 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is -6.67% vs 73.08% in Jun 2025

YoY Growth in quarter ended Sep 2025 is -19.23% vs 26.83% in Sep 2024

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 13.52%

in Sep 2025

Figures in %

QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025

YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024